MACS® GMP PepTivator® Mucin-1

The MACS GMP PepTivator Mucin-1 is a peptide pool that consists mainly of 15-mer peptides. It has been developed for efficient in vitro stimulation and subsequent isolation of Mucin-1-specific CD4+ and CD8+ T cells.

Related products for MACS® GMP PepTivator® Mucin-1

Specifications for MACS® GMP PepTivator® Mucin-1
Overview

The MACS GMP PepTivator Mucin-1 is a peptide pool that consists mainly of 15-mer peptides. It has been developed for efficient in vitro stimulation and subsequent isolation of Mucin-1-specific CD4+ and CD8+ T cells.

Detailed product information
Background information

Mucin-1 is expressed on epithelial cells in different mucosal tissue like lung, stomach, breast or pancreas. The overexpression is associated with Adenocarcinoma, Lymphoma and Multiple Myeloma and is used as serological clinical marker of breast cancer. This makes Mucin-1 to an attractive target for anticancer immunotherapy.1-5

Applications

The MACS GMP PepTivator Mucin-1 is used for in vitro stimulation of Mucin-1-effector and memory T cells.

Adoptive transfer of Mucin-1-specific T cells or vaccination with Mucin-1-pulsed dendritic cells may be an effective tool for the treatment of Mucin-1-expressing malignancies.

This product has not yet been tested in conjunction with the CliniMACS Cytokine Capture System (IFN-gamma).

Quality statement

MACS GMP Products are manufactured and tested under a quality management system (ISO 13485) and are in compliance with relevant GMP guidelines. They are designed following the recommendations of USP <1043> on ancillary materials.

Disclaimer

MACS GMP Products are for ex vivo cell processing only, and are not intended for human in vivo applications. For regulatory status in the USA, please contact your local representative.

Resources for MACS® GMP PepTivator® Mucin-1
Certificates

Enter the lot number from your product label to access its Product Quality Certificated (PQC).

Get certificate

Citations for MACS® GMP PepTivator® Mucin-1
Publications
  1. Brossart, P. et al. (2001) The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res. 61 (18): 6846-6850
  2. Lau S. K. et al. (2004) Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am. J. Clin. Pathol. 122 (1): 61-69
  3. Taylor-Papadimitriou, J. et al. (1999) MUC1 and cancer. Biochim. Biophys. Acta 1455 (2-3): 301-313
  4. Lacunza E. et al. (2010) MUC1 oncogene amplification correlates with protein overexpression in invasive breast carcinoma cells. Cancer Genet Cytogenet 201 (2): 102-110
  5. Oosterkamp, H. M. et al. (1997) Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z). Int. J. Cancer 72 (1): 87-94